Refractive Outcomes of 4-Year-old Children after Intravitreal Anti-vascular Endothelial Growth Factor versus Laser Photocoagulation for Retinopathy of Prematurity
Hyun Goo Kang, Tae Young Kim, Jinu Han, Sueng-Han Han
Korean J Ophthalmol. 2019;33(3):272-278.   Published online 2019 Jun 4     DOI: https://doi.org/10.3341/kjo.2019.0011
Citations to this article as recorded by Crossref logo
Refractive outcomes after intravitreal injection of antivascular endothelial growth factor versus laser photocoagulation for retinopathy of prematurity: a meta-analysis
Qihang Kong, Wai-kit Ming, Xue-Song Mi
BMJ Open.2021; 11(2): e042384.     CrossRef
Intravitreal antivascular endothelial growth factor injection versus laser photocoagulation for retinopathy of prematurity: A meta-analysis of 3,701 eyes
Marko M. Popovic, Prem Nichani, Rajeev H. Muni, Kamiar Mireskandari, Nasrin N. Tehrani, Peter J. Kertes
Survey of Ophthalmology.2020;[Epub]     CrossRef
Development of refractive error in children treated for retinopathy of prematurity with anti-vascular endothelial growth factor (anti-VEGF) agents: A meta-analysis and systematic review
Qing-Qing Tan, Stephen P. Christiansen, Jingyun Wang, Der-Chong Tsai
PLOS ONE.2019; 14(12): e0225643.     CrossRef